reduces the blood flow.Thiazide diuretics block the reabsorption of sodium chloride and water in the ascending limb of the loop of Henle and early distal tubule. Thus, interfere with urinary dilation. (2)Gemfibrizol reduces incorporation of long fatty acids into newly formed triglycerides. Thus reduces the very low-density lipoprotein production in the liver. It also controls lipoprotein lipase activity. It effects and elevates HDL cholesterol and reduces triglycerides, and LDL and VLDL cholesterol.Nutritional Concerns (drug/nutrient interactions, patient education)(1)Some medicines or medical conditions may interact with this medicine. This medicine should not be taken if patient is taking ketanserin. Also, monitoring may be needed if patient is taking diazoxide, digitoxin, digoxin, or lithium. Patient needs to drink lots of fluid with medication because if not, it can lead to lightheadedness and fainting. Medicine may cause increase sensitivity to sun, thus patient needs avoid exposure to the sun, sunlamps, or tanning booths. Also, no salt substitutes and potassium supplements should be taken without consulting physician. Patient should not breast feed if taking medication. If patient has diabetes, this medicine may affect your blood sugar. (2)The patient should not stop taking this medication. The medicine may cause blurred vision or dizziness, thus it is advised that patient does not drive, operate any machinery, or do anything dangerous until effects of drug are seen. If the patient is pregnant, she should not breast feed while taking medication.GKMs medical nutritional therapy was assessed with several measures. Her nutritional status is poor, with an unbalanced, non-nutritional diet and lack of exercise that has caused her obesity. Due to the obesity and no change in diet, GKMs progress in getting better is a slow process, even though the intervention of drug therapy has been given for the past 3 months prior to he...
